[
  {
    "ts": null,
    "headline": "Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care",
    "summary": "Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its previously announced acquisition of select clinical testing assets of Fresenius Medical Care's wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the United States. With this acquisition, Quest will be positioned to provide dialysis-related clinical testing to independent dialysis clinics previously served by Spectra Labor",
    "url": "https://finnhub.io/api/news?id=ccad8515c20babcab5fd3cdb59d2df85800662348bef5c98cbb24f03d3f7fce8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754397180,
      "headline": "Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care",
      "id": 136212806,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its previously announced acquisition of select clinical testing assets of Fresenius Medical Care's wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the United States. With this acquisition, Quest will be positioned to provide dialysis-related clinical testing to independent dialysis clinics previously served by Spectra Labor",
      "url": "https://finnhub.io/api/news?id=ccad8515c20babcab5fd3cdb59d2df85800662348bef5c98cbb24f03d3f7fce8"
    }
  }
]